Massachusetts · 194th Legislature (2025-2026) · Bill

H 2217: An Act relative to opioid reversal drugs

In committee Last action March 30, 2026: Accompanied a study order, see H5319 (under House Rule 27)

Plain-language summary

H 2217 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act relative to opioid reversal drugs. Primary sponsor: Sally Kerans (Democratic). Most recent recorded action (March 30, 2026): Accompanied a study order, see H5319 (under House Rule 27).

Sponsors

Primary sponsor: Sally Kerans (Democratic).